SCHEMBL4282889

SCHEMBL4282889

N#Cc1ccc(NCCN[N+]23C=C(c4ccc(Cl)cc4Cl)N=CC2=NC=N3)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 6/20 0.45
CCNB2 O95067 1/20 0.45
CDK1 P06493 1/20 0.45
CCNB1 P14635 1/20 0.45
RPS6KB1 P23443 1/20 0.45
CDK2 P24941 1/20 0.45
GSK3A P49840 1/20 0.45
LIMK1 P53667 1/20 0.45
TAOK1 Q7L7X3 1/20 0.45
CCNB3 Q8WWL7 1/20 0.45
SLK Q9H2G2 1/20 0.45
CLK4 Q9HAZ1 1/20 0.45
CSNK1G1 Q9HCP0 1/20 0.45
IDH1 O75874 2/20 0.36
TMPRSS4 Q9NRS4 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.31
DPP4 P27487 6/20 0.31
DPP7 Q9UHL4 2/20 0.30
DPP8 Q6V1X1 1/20 0.30
CCR6 P51684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2928121 0.84 GSK3B (0.32) GSK3BCCNB2CDK1CCNB1RPS6KB1
SCHEMBL2926625 0.84 CNR1 (0.33) GSK3BCCNB2CDK1CCNB1RPS6KB1
Hydrochloric Acid SCHEMBL4283482 0.84 GSK3B (0.32) GSK3BCCNB2CDK1CCNB1RPS6KB1
SCHEMBL2935929 0.73 GSK3B (0.33) GSK3BCCNB2CDK1CCNB1GSK3A
SCHEMBL2934351 0.72 CCR6 (0.41) GSK3BTMPRSS4DPP4CCR6
SCHEMBL13300067 0.71 GSK3B (0.59) GSK3BCCNB2CDK1CCNB1RPS6KB1
SCHEMBL13300098 0.69 GSK3B (0.51) GSK3BCCNB2CDK1CCNB1RPS6KB1
SCHEMBL13300243 0.69 GSK3B (0.56) GSK3BCCNB2CDK1CCNB1RPS6KB1
SCHEMBL6069368 0.68 GSK3B (0.51) GSK3BCCNB2CDK1CCNB1RPS6KB1
SCHEMBL2931661 0.68 AHR (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090258877-A1 TRIAZOLOTRIAZINES AND TRIAZOLOPYRAZINES AND THEIR USE BAYER HEALTHCARE AG (DE) 2009-10-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258877-A1 TRIAZOLOTRIAZINES AND TRIAZOLOPYRAZINES AND THEIR USE THPO, IL5, TPMT GSK3B 2707/4885CCNB2 1130/4885CDK1 1240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.